| Backlog (Q4 2025) | $793M | CFO |
| Orders (Q4 2025) | $329M | CFO |
| Orders (Full Year 2025) | $1.064B | CFO |
| Revenue (Q4 2025) | $215M | CFO |
| Revenue (Full Year 2025) | $774M | CFO |
| Adjusted EBITDA (Q4 2025) | $29.8M | CFO |
| Adjusted EBITDA margin (Q4 2025) | 13.9% | CFO |
| Adjusted EBITDA (Full Year 2025) | >$90M | CFO |
| Gross margin (TTM, Q4) | >35% | CFO |
| Book-to-bill (Q4 2025) | ~1.5x | CFO |
| Book-to-bill (Full Year 2025) | ~1.4x | CFO |
| Free cash flow (Full Year 2025) | ~$10M | CFO |
| Net leverage ratio | 2.2x | CFO |
| Liquidity | $124M | CFO |
| Q1 2026 orders (thru Feb 24) | >$270M | CEO |
| Sales pipeline | >$6.5B | CFO, CEO |
| Pro forma combined revenue | ~$1.5B | CEO |
| Pro forma combined adjusted EBITDA (incl. synergies) | ~$295M | CEO |